IP Library › Granted Patent US 7,427,639
Granted Patent B2
US 7,427,639 · App. 11/784,148 · Granted Sep 23, 2008

β2-adrenergic receptor agonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,427,639
App. No.
11/784,148
Granted
Sep 23, 2008
Kind
B2
Abstract

Disclosed are multibinding compounds which are β2 adrenergic receptor agonists and are useful in the treatment and prevention of respiratory diseases such as asthma, bronchitis. They are also useful in the treatment of nervous system injury and premature labor.

Claims (4)

1. A compound of the formula:

2. A pharmaceutically acceptable salt of a compound of the formula:

3. A pharmaceutical composition comprising a pharmaceutically-acceptable carrier and a therapeutically effective amount of a compound of the formula:

4. A pharmaceutical composition comprising a pharmaceutically-acceptable carrier and a therapeutically effective amount of a pharmaceutically acceptable salt of a compound of the formula:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 033181/0693 →